Notal Vision
Candice Morin is an experienced communications and marketing professional with a career spanning over 15 years in various leadership roles. As the Communications Director at Notal Vision since 2017, Candice has led digital marketing initiatives, managed company events, overseen website management, and coordinated promotional marketing review processes. Prior to this, Candice served as the Group Director of Communications at Ocean House Management, where responsibilities included brand development, public relations, and online marketing management. Candice also has extensive event coordination experience from roles at the Mystic Museum of Art and Global Conferences Africa, and has contributed to marketing efforts for organizations such as EuroRSCG Life and Red Bull. Candice holds a BA in Public Relations and Communications from the University of Rhode Island.
This person is not in any teams
This person is not in any offices
Notal Vision
Notal Vision is a patient-centric ophthalmic remote monitoring services provider extending retinal disease monitoring from the clinic to the home, providing physicians with remote monitoring services to support their patient care between office visits. With a proven approach to home-based, self-operated diagnostics, AI-enabled data analysis, and patient engagement, we help preserve patients’ vision. The Notal Vision Monitoring Center is a remote, Medicare credentialed ophthalmic provider and the epicenter of patient engagement. Led by practicing ophthalmologists and supported by certified ophthalmic professionals, the Monitoring Center offers a comprehensive nationwide age-related macular degeneration (AMD) home monitoring service for referred patients. The ForeseeHome® AMD Monitoring Program helps physicians detect the conversion to wet AMD early, leading to earlier treatment intervention and better visual outcomes. Our Home OCT pipeline technology will provide patient-initiated retinal OCT scans to support the management of patients with neovascular retinal diseases, complementing existing in-office imaging and standard of care treatments as well as emerging longer acting drugs and drug delivery systems.